BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 9808873)

  • 41. Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction.
    Merlini PA; Cugno M; Rossi ML; Agricola P; Repetto A; Fetiveau R; Diotallevi P; Canosi U; Mannucci PM; Ardissino D
    Am J Cardiol; 2004 Apr; 93(7):822-5. PubMed ID: 15050482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry).
    Grajek S; Lesiak M; Araszkiewicz A; Pyda M; Skorupski W; Grygier M; Mitkowski P; Prech M; Baszko A; Janus M; Breborowicz P; Rzeźniczak J; Tarchalski J; Główka A; Cieśliński A
    Kardiol Pol; 2008 Feb; 66(2):154-63; discussion 164-5. PubMed ID: 18344153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP; Tschopp TB; Kuhn H; Steiner B; Hadváry P
    J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
    Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality].
    Charbonnier B
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Advantages of immediate coronary dilatation after thrombolysis using tissue-type plasminogen activator in acute myocardial infarction. A European Cooperative Group trial].
    Vahanian A
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():39-43. PubMed ID: 2973300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet function after in vivo and in vitro treatment with thrombolytic agents.
    Bertolino G; Noris P; Previtali M; Gamba G; Ferrario M; Montani N; Balduini CL
    Am J Cardiol; 1992 Feb; 69(5):457-61. PubMed ID: 1736606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo platelet activation following myocardial infarction and acute coronary ischaemia.
    Hughes A; Daunt S; Vass G; Wickes J
    Thromb Haemost; 1982 Oct; 48(2):133-5. PubMed ID: 6184842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time course of platelet alpha granule release in acute myocardial infarction treated with streptokinase.
    Frandsen NJ; Winther K; Pedersen F; Christiansen I; McNair P
    Heart; 1996 Feb; 75(2):141-4. PubMed ID: 8673751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the kinetics of MB creatine kinase in patients undergoing systemic thrombolytic therapy].
    Arrigo F; Saccà CM; Cavalli A; Egitto M; Barillari M; Costa G; Cavalli G; Carerj S; Melluso C
    Cardiologia; 1991 Nov; 36(11):861-6. PubMed ID: 1817758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].
    López Bescós L
    Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary thrombolysis: practical considerations.
    Eisenberg PR; Jaffe AS
    Cardiol Clin; 1987 Feb; 5(1):129-41. PubMed ID: 3103918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-thromboglobulin plasma levels in the first week after myocardial infarction: influence of thrombolytic therapy.
    Salvioni A; Marenzi G; Lauri G; Giraldi F; Perego GB; Grazi S; Guazzi MD
    Am Heart J; 1994 Sep; 128(3):472-6. PubMed ID: 8074007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
    Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
    Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].
    Acar J; Dorent R; Vahanian A; Michel PL; Cormier B; Slama M; Cazaux P; Conard J; Verdy E; Samama M
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():59-65. PubMed ID: 3142430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.